Life sciences · Interventional Study
ClinicalTrials.gov · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07372729). This is a study registration, not published results. Lead sponsor: Beijing Anzhen Hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 1400 participants (ESTIMATED). Conditions: Overweight , Obesity, Prediabetes, High-normal Blood Pressure, Borderline Elevated Blood Lipids. Interventions: BEHAVIORAL: Smartwatch-Based Multi-Faceted Behavioral Intervention Model Led by Exercise and Dietary Interventions, Supported by Primary Medical Staff, Along with the Distribution of Health Education Manuals; BEHAVIORAL: Face-to-face health education sessions. Primary outcome measures: Change in Life's Essential 8 risk score , Baseline and 6 months after intervention. Brief summary: This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among metabolically at-risk people with overweight/obesity, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.